Dr. Carmen Roxana Fuentes, MD

Dr. Fuentes practices at Sentara Princess Anne Hospital in Virginia Beach, Virginia, part of Sentara Health.

Dr. Fuentes' NPI, 1639361033, was assigned on August 10, 2007. Dr. Fuentes graduated from Universidad Autonoma de Guadalajara in 2002. Dr. Fuentes' Louisiana license number on file is MD.202662.

Dr. Fuentes' primary practice is Sentara Princess Anne Hospital, at 2025 Glenn Mitchell Drive, Virginia Beach, VA 23456 in Virginia Beach City. The practice phone is (757) 507-1520.

Dr. Fuentes' primary practice is Sentara Princess Anne Hospital in Virginia Beach, Virginia, part of Sentara Health. Dr. Fuentes is also affiliated with Sentara Virginia Beach General Hospital. The medical group on file is Virginia Beach Neurology. Dmand AI also links Dr. Fuentes to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fuentes practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fuentes' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Fuentes is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Fuentes' licenses on file in 3 states: Louisiana, Virginia and North Carolina.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Fuentes treats.

CMS data shows 55,535 Medicare services from Dr. Fuentes across 13 procedure codes in 2024, for 707 Medicare patients. Medicare paid $233,603 for them. Every service was in an office.

CMS counts 707 Medicare patients who saw Dr. Fuentes in 2024. The largest group is 75 to 84, with 310 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fuentes' median patient age at 73, with 53% women.

In 2024, Dr. Fuentes wrote 3,119 Medicare Part D claims for 546 patients. 85% of them were for generic drugs. CMS names the drug for 2,847 of them, across 42 drugs with 11 or more claims each, at $2,095,836 in total drug cost. In 2023, CMS named 2,302 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Fuentes for performance year 2024, reported as part of a group. Dr. Fuentes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fuentes as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Fuentes in 2010. The most frequent topics are Cats, Nerve Degeneration and Auditory Cortex. Dr. Fuentes has published most often in Z Mikrosk Anat Forsch. Dr. Fuentes' most frequent co-author is Daniel Masvidal, MD.

Dmand AI links Dr. Fuentes to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Delusions, Migraine Disorders and Multiple Sclerosis, Relapsing-Remitting. Open Payments lists research payments to Dr. Fuentes that name 2 trials.

CMS Open Payments shows 699 general payments to Dr. Fuentes from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $195,409. It also lists 9 research payments totaling $35,404 from 2019 to 2023, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Fuentes, most recently CMS Stage 1 2012 in 2011.

Dr. Fuentes graduated from Universidad Autonoma de Guadalajara in 2002. Dr. Fuentes is a member of AAN and MDS.

Dr. Fuentes is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.